K. Tahara

Pharmacokinetics and pharmacodynamics of bisoprolol in rats with bilateral ureter ligation-induced renal failure.

M. Taguchi, Y. Hashimoto, K. Tahara, 2006, Drug metabolism and pharmacokinetics.

Influence of CYP2D6 Genotype on Metoprolol Plasma Concentration and β-Adrenergic Inhibition During Long-Term Treatment: A Comparison With Bisoprolol

T. Nozawa, H. Inoue, M. Nonomura, 2005, Journal of cardiovascular pharmacology.

Nonlinear mixed effects model analysis of the pharmacokinetics of routinely administered bepridil in Japanese patients with arrhythmias.

H. Inoue, M. Taguchi, A. Fujiki, 2006, Biological & pharmaceutical bulletin.

Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.

M. Taguchi, Y. Hashimoto, K. Tahara, 2008, Drug metabolism and pharmacokinetics.

Pharmacokinetic variability of routinely administered bisoprolol in middle-aged and elderly Japanese patients.

T. Nozawa, H. Inoue, M. Taguchi, 2005, Biological & pharmaceutical bulletin.

Nonlinear mixed effects model analysis of the pharmacokinetics of metoprolol in routinely treated Japanese patients.

T. Nozawa, H. Inoue, M. Taguchi, 2004, Biological & pharmaceutical bulletin.

Pharmacokinetic analysis of transcellular transport of levofloxacin across LLC-PK1 and Caco-2 cell monolayers.

Y. Hashimoto, K. Tahara, K. Ishida, 2007, Biological & pharmaceutical bulletin.

The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.

M. Taguchi, Y. Hashimoto, K. Tahara, 2008, Drug metabolism and pharmacokinetics.